FCH
TSRX

Freestone Capital Holdings’s TRIUS THERAPEUTICS INC COM STK (DE) TSRX Stock Holding History

Freestone Capital Holdings’s Portfolio TSRX Stock Details TSRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-16,000
Closed -$93K – 429
2013
Q3 		$93K Buy
+16,000
New +$197K 0.02% 339

Other funds holding TSRX

AC
Amici Capital New York $257M AUM 4.88% 1-Year Est. Return

Freestone Capital Holdings's TSRX Position: Q4 2013 in Review

Freestone Capital Holdings sold out of TRIUS THERAPEUTICS INC COM STK (DE) (TSRX) in Q4 2013, closing a stake of 16,000 shares — an estimated $93K sold.

Freestone Capital Holdings first reported a position in TSRX in Q3 2013 and held it in 1 quarter. The position peaked at $93K in Q3 2013. 1 fund tracked by Wall St. Rank holds TSRX as of Q4 2013.

  • Freestone Capital Holdings reported no remaining TRIUS THERAPEUTICS INC COM STK (DE) position as of Q4 2013 after selling out during the quarter.
  • Freestone Capital Holdings sold 16,000 TRIUS THERAPEUTICS INC COM STK (DE) shares in Q4 2013, an estimated $93K.
  • Freestone Capital Holdings first reported a position in TRIUS THERAPEUTICS INC COM STK (DE) in Q3 2013 and held it in 1 quarter.
  • Freestone Capital Holdings's TRIUS THERAPEUTICS INC COM STK (DE) position peaked at $93K in Q3 2013.
  • 1 fund tracked by Wall St. Rank held TRIUS THERAPEUTICS INC COM STK (DE) as of Q4 2013.

Based on Freestone Capital Holdings's 13F filing for Q4 2013, filed 13 Feb 2014.